The partnership aims to strengthen Europa Biosite’s presence in the UK and Ireland
Bio X Cell has made Cambridge Bioscience, a member of Europa Biosite, its exclusive distributor for the UK and Ireland.
The partnership will give researchers in the UK and Ireland access to the Bio X Cell portfolio, featuring functional monoclonal antibodies, globally recognised for their high quality, purity, and consistency in in vivo, ex vivo, new approach methodologies (NAMs), and other sensitive studies.
Cambridge Bioscience has been a trusted partner to academic institutions and biotech companies across the UK and Ireland for over four decades, collaborating with the University of Cambridge, University of Oxford, University College London, and Trinity College Dublin.
Cambridge Bioscience aims to strengthen Europa Biosite's presence in the UK and Ireland by leveraging its expertise in life science distribution, customer-centric support, and a proven track record of aiding researchers in advancing biomedical research.
Sune Schmolker, CEO of Europa Biosite, said, “We have for many years distributed the innovative and well-documented antibodies of Bio X Cell in Nordics and Switzerland, and I am very pleased in the trust put in us expanding our collaboration into UK and Ireland. Signing of the exclusive distributor contract strengths our partnership and underscores a shared commitment to raising the standard of life science reagents and providing researchers with unparalleled access to quality products and services.”
Christopher Conway, CEO, Bio X Cell, said, "We are thrilled to partner with Cambridge Bioscience to better serve the UK and Irish scientific communities. Bio X Cell’s partnership with Cambridge Bioscience deepens our expertise and commitment to enabling global research with the highest quality functional antibodies. Cambridge Bioscience’s customer-focused philosophy makes them an ideal partner to help us provide even greater support to researchers conducting critical biomedical studies."
